- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Scientific Poster Download
Poster modified on 17/10/2023
Developability Assessment and Optimization of Antibodies and Antibody-derived Molecules at Early-Stage Discovery
Weijie Zhang, Nan Feng, Shuang Wang, Hang Zhou, Jianqing Xu, Jijie Gu and Zhuozhi Wang
WuXi Biologics, 1951 West Huifeng Road, Fengxian District, Shanghai, China
Although the safety and efficacy of a drug candidate are evaluated by sponsors and regulatory agencies, many aspects of developability of a given antibody candidate during early drug R&D are sometimes overlooked. In this poster, we outline our novel criterion of developability and general developability screening process during the early discovery stage of antibody-derived therapeutics.
This scientific poster was originally presented during the Festival of Biologics 2023 conference
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.